Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropathology and applied neurobiology 2012-02, Vol.38 (1), p.105-110
Hauptverfasser:	Yoshikawa, A., Nakada, M., Ohtsuki, S., Hayashi, Y., Obuchi, W., Sato, Y., Ikeda, C., Watanabe, T., Kawahara, Y., Hasegawa, T., Sabit, H., Kita, D., Nakanuma, Y., Terasaki, T., Hamada, J.I.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Antineoplastic Agents - therapeutic use Biological and medical sciences Chemotherapy Chromatography, High Pressure Liquid Female Humans Immunohistochemistry Indexing in process Indoles - therapeutic use Medical sciences Meningeal Neoplasms - drug therapy Meningeal Neoplasms - metabolism Meningeal Neoplasms - pathology Meningioma - drug therapy Meningioma - metabolism Meningioma - pathology Middle Aged Molecular Targeted Therapy - methods Neurology Pharmacology. Drug treatments Proteomics - methods Pyrroles - therapeutic use Receptor, Platelet-Derived Growth Factor beta - analysis Receptor, Platelet-Derived Growth Factor beta - biosynthesis Spectrometry, Mass, Electrospray Ionization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!